CN114767582A - Cream for promoting balanced secretion of hormones and preparation method thereof - Google Patents
Cream for promoting balanced secretion of hormones and preparation method thereof Download PDFInfo
- Publication number
- CN114767582A CN114767582A CN202210442891.0A CN202210442891A CN114767582A CN 114767582 A CN114767582 A CN 114767582A CN 202210442891 A CN202210442891 A CN 202210442891A CN 114767582 A CN114767582 A CN 114767582A
- Authority
- CN
- China
- Prior art keywords
- parts
- phase
- extract
- composition
- cream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000005556 hormone Substances 0.000 title claims abstract description 52
- 229940088597 hormone Drugs 0.000 title claims abstract description 52
- 239000006071 cream Substances 0.000 title claims abstract description 44
- 230000028327 secretion Effects 0.000 title claims abstract description 29
- 230000001737 promoting effect Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 117
- 239000000284 extract Substances 0.000 claims abstract description 82
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 14
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 claims abstract description 14
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 14
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 11
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 8
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 7
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 7
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000009141 Houttuynia cordata plant extract Substances 0.000 claims abstract description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims abstract description 7
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 7
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 7
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 7
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 7
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 7
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims abstract description 7
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 7
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 7
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 7
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 7
- 229960003237 betaine Drugs 0.000 claims abstract description 7
- 239000008367 deionised water Substances 0.000 claims abstract description 7
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 7
- 229930182478 glucoside Natural products 0.000 claims abstract description 7
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 7
- 229940041616 menthol Drugs 0.000 claims abstract description 7
- 229960001238 methylnicotinate Drugs 0.000 claims abstract description 7
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940075529 glyceryl stearate Drugs 0.000 claims abstract description 6
- 240000007890 Leonurus cardiaca Species 0.000 claims abstract 2
- 238000003756 stirring Methods 0.000 claims description 24
- 238000001816 cooling Methods 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 17
- 238000005086 pumping Methods 0.000 claims description 14
- 230000001804 emulsifying effect Effects 0.000 claims description 13
- 229920001661 Chitosan Polymers 0.000 claims description 12
- 230000032683 aging Effects 0.000 claims description 11
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 claims description 6
- 241000596154 Belamcanda Species 0.000 claims description 6
- 241000167550 Centella Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 229940041514 candida albicans extract Drugs 0.000 claims description 6
- 239000000084 colloidal system Substances 0.000 claims description 6
- 239000001599 crocus sativus l. flower extract Substances 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 6
- 229940119170 jojoba wax Drugs 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 6
- 229960002216 methylparaben Drugs 0.000 claims description 6
- 229940076591 saffron extract Drugs 0.000 claims description 6
- 238000005070 sampling Methods 0.000 claims description 6
- 229940078465 vanillyl butyl ether Drugs 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 6
- 229940082509 xanthan gum Drugs 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- 239000012138 yeast extract Substances 0.000 claims description 6
- 240000001341 Reynoutria japonica Species 0.000 claims description 5
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 238000004945 emulsification Methods 0.000 claims description 4
- 238000000265 homogenisation Methods 0.000 claims description 4
- 239000002243 precursor Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 abstract 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 abstract 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 abstract 1
- 235000012141 vanillin Nutrition 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010046543 Urinary incontinence Diseases 0.000 description 3
- 206010071018 Urogenital atrophy Diseases 0.000 description 3
- 230000037315 hyperhidrosis Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 244000288157 Passiflora edulis Species 0.000 description 2
- 235000000370 Passiflora edulis Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 244000153955 Reynoutria sachalinensis Species 0.000 description 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000003688 hormone derivative Substances 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a cream for promoting hormone balanced secretion and a preparation method thereof, relating to the technical field of skin care product preparation methods, wherein the cream specifically comprises the following components: the phase A composition is prepared from glyceryl stearate, polydimethylsiloxane, methyl hydroxybenzoate, menthol lactate, methyl nicotinate, isostearyl glucoside, and propylene glycol; vanillin butyl ether; the composition of phase B consists of deionized water, glycerol and betaine; the C phase composition comprises stigma croci Sativi extract, maca extract, Scutellariae radix extract, and herba Centellae extract; the phase D composition comprises oligopeptide and phenoxyethanol; the traditional Chinese medicine composition comprises an angelica sinensis extract, a pseudo-ginseng extract, a houttuynia cordata extract, a dried orange peel extract, a motherwort extract, a cordyceps militaris powder extract and a wolfberry fruit powder extract, and when the components are used synergistically, the traditional Chinese medicine composition can nourish primordial qi, provide sufficient hormone precursor substances for skin, balance male hormones and improve the vitality of organisms.
Description
Technical Field
The invention relates to the technical field of preparation methods of skin care products, and in particular relates to cream for promoting balanced secretion of hormones and a preparation method thereof.
Background
Hormones, which are commonly called "hormones" and are the general term of hormones secreted by the endocrine system of the human body and capable of regulating physiological functions, all the time, the hormones operate in the blood of the human body, control a plurality of functions of the human body, support and activate various organs in the body, and promote metabolism. The influence of the hormone content in the body on the physical and psychological states of the human body is very important, and what is more important, the hormone content is classified as a measuring agent for female adolescence.
Hormones are decreasing with age and also cause aging. Aging, also called aging, refers to the process of the body of human being with the change of tissue structure, the function decline, the decrease of adaptability, the decrease of organ stress ability and the gradual loss of life ability along with the increase of age or time after the development and maturation; from the research of the whole organ level and molecular cells, the aging is related to the factors of genetic genes, free radicals, endocrine dysfunction and immune dysfunction, the aging is limited to the whole body, and the skin aging is more obvious and is characterized by wrinkles, laxity, pigmentation and the like.
At present, hormone cream on the market is mainly used for regulating hormones, and is based on a natural hormone precursor therapy, like common yam cream, contains more auxiliary chemical components such as hyaluronic acid and is difficult to absorb.
Disclosure of Invention
The invention aims to provide a cream for promoting balanced secretion of hormones and a preparation method thereof; the following technical problems are solved:
at present, hormone cream on the market mainly aims at conditioning hormones, adopts natural hormone precursor therapy as a basis, and like common yam cream, contains more auxiliary chemical components such as hyaluronic acid and the like and is not easy to absorb.
The purpose of the invention can be realized by the following technical scheme:
a cream for promoting hormone balance secretion comprises phase A composition, phase B composition, phase C composition, phase D composition and Chinese medicinal composition;
the phase A composition consists of the following components in parts by weight:
5-15 parts of glyceryl stearate, 4-8 parts of polydimethylsiloxane, 5-10 parts of methylparaben, 3-6 parts of menthol lactate, 2-7 parts of methyl nicotinate, 4-9 parts of isostearyl glucoside and 3-5 parts of propylene glycol; 1-4 parts of vanillyl butyl ether;
the phase B composition consists of the following components in parts by weight:
20-30 parts of deionized water, 5-9 parts of glycerol and 3-7 parts of betaine;
the phase C composition consists of the following components in parts by weight:
2-5 parts of saffron extract, 3-6 parts of maca extract, 1-4 parts of scutellaria root extract and 2-4 parts of centella extract;
the phase D composition consists of the following components in parts by weight:
0.5-1.5 parts of oligopeptide and 2-4 parts of phenoxyethanol;
the traditional Chinese medicine composition comprises the following components in parts by weight:
6-10 parts of angelica sinensis extract, 3-7 parts of pseudo-ginseng extract, 1-5 parts of houttuynia cordata extract, 2-6 parts of dried orange peel extract, 1-3 parts of motherwort extract, 3-5 parts of cordyceps militaris powder extract and 4-8 parts of wolfberry fruit powder extract.
Preferably, the phase A composition further comprises the following components in parts by weight: 1-3 parts of blackberry lily root extract and 2-6 parts of hundred flower fruit extract.
Preferably, the phase B composition further comprises the following components in parts by weight: 1-5 parts of xanthan gum and 0.5-2 parts of chitosan.
Preferably, the phase C composition further comprises the following components in parts by weight: 0.2-0.8 part of giant knotweed root extract and 0.3-0.9 part of yeast extract.
Preferably, the phase D composition further comprises the following components in parts by weight: 0.2-0.8 parts of jojoba oil.
Preferably, the relative molecular weight of the chitosan is 20000-30000.
A preparation method of a cream for promoting balanced secretion of hormones specifically comprises the following steps:
step S1, weighing the phase A composition, the phase B composition, the phase C composition, the phase D composition and the traditional Chinese medicine composition in sequence according to the weight parts;
step S2, heating the A-phase composition to 85-95 ℃, preserving heat for 20-30min, and cooling to 80 ℃;
step S3, heating the B phase composition to 95-100 ℃, keeping the temperature for 20-30min after the colloid is completely dispersed, and cooling to 85 ℃;
step S4, pumping the mixed phase prepared in the step S3 into a preheated emulsifying pot, slowly pumping the mixed phase into the phase A component mixture prepared in the step S2, pre-emulsifying for 20-25min, homogenizing for 10-15min, stirring uniformly, and vacuumizing for defoaming;
step S5, adding the Chinese medicinal composition into the mixed solution obtained by emulsification in the step S4, heating to 95-100 ℃ again, keeping for 10-15min, and cooling after homogenization treatment;
step S6, when the temperature is reduced to 55 ℃, adding the component C, keeping the temperature, stirring and homogenizing the mixture uniformly, and then continuously reducing the temperature, wherein the temperature floating range is between 2 and 4 ℃;
step S7, adding the component D when the temperature is reduced to 45 ℃, keeping the temperature, stirring and homogenizing the mixture uniformly when the temperature is in a floating range of 1-2 ℃, and then continuously reducing the temperature;
step S8, when the temperature is reduced to normal temperature, after the sampling analysis result is qualified, discharging to obtain cream for promoting hormone balanced secretion;
and step S9, pushing the obtained cream out of the pot to a standing chamber, aging for 12 hours, and then filling.
Preferably, in the step S4, the vacuum degree of the vacuum pumping is between-0.08 Mpa and-0.1 Mpa, and the defoaming is carried out for 5 to 10 hours.
Preferably, in the step S4-step S7, the stirring speed is 40-50 rpm.
The invention has the beneficial effects that:
(1) according to the traditional Chinese medicine composition, the angelica sinensis extract, the pseudo-ginseng extract, the houttuynia cordata extract, the dried orange peel extract, the motherwort extract, the cordyceps militaris powder extract and the wolfberry fruit powder extract are matched in a specific ratio, so that the obtained composition product can nourish vigor when being used synergistically, sufficient hormone precursor substances are provided for skin, male hormones are balanced, and the organism activity is improved;
(2) the invention belongs to plant hormones, and the special plant components can stimulate the human body to generate the required hormones by self and maintain a balanced state, so that the adverse effects of excessive hormones and synthetic hormones can not be generated;
(3) the cream for promoting balanced secretion of hormones does not depend on the supplement of a single hormone product, and cannot stimulate a human body to generate tumor cells and damage organs.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A preparation method of cream for promoting balanced secretion of hormones specifically comprises the following steps:
step S1, weighing the phase A composition, the phase B composition, the phase C composition, the phase D composition and the traditional Chinese medicine composition in sequence according to the weight parts;
the phase A composition comprises the following components in parts by weight:
5 parts of glyceryl stearate, 4 parts of polydimethylsiloxane, 5 parts of methylparaben, 3 parts of menthol lactate, 2 parts of methyl nicotinate, 4 parts of isostearyl glucoside and 3 parts of propylene glycol; 1 part of vanillyl butyl ether, 1 part of blackberry lily root extract and 2 parts of hundred flower fruit extract;
the phase B composition consists of the following components in parts by weight:
20 parts of deionized water, 5 parts of glycerol, 3 parts of betaine, 1 part of xanthan gum and 0.5 part of chitosan, wherein the relative molecular weight of the chitosan is 20000;
the phase C composition consists of the following components in parts by weight:
2 parts of saffron extract, 3 parts of maca extract, 1 part of scutellaria root extract, 2 parts of centella extract, 0.2 part of polygonum cuspidatum root extract and 0.3 part of yeast extract;
the phase D composition consists of the following components in parts by weight:
0.5 part of oligopeptide, 2 parts of phenoxyethanol and 0.2 part of jojoba oil;
the traditional Chinese medicine composition comprises the following components in parts by weight:
6 parts of angelica sinensis extract, 3 parts of pseudo-ginseng extract, 1 part of houttuynia cordata extract, 2 parts of dried orange peel extract, 1 part of motherwort extract, 3 parts of cordyceps militaris powder extract and 4 parts of wolfberry fruit powder extract.
Step S2, heating the composition of the A phase to 85 ℃, preserving heat for 20min, and cooling to 80 ℃;
step S3, heating the B-phase composition to 95 ℃, and cooling to 85 ℃ after the colloid is completely dispersed and the temperature is kept for 20 min;
step S4, pumping the mixed phase prepared in the step S3 into a preheated emulsifying pot, slowly pumping the mixed phase A component mixture prepared in the step S2, pre-emulsifying for 20min, homogenizing for 10min, stirring uniformly, vacuumizing and defoaming for 5 hours, wherein the vacuum degree of vacuumizing is-0.08 MPa;
step S5, adding the Chinese medicinal composition into the mixed solution obtained by emulsification in the step S4, heating to 95 ℃ again, keeping for 10min, and cooling after homogenization treatment;
step S6, when the temperature is reduced to 55 ℃, adding the component C, keeping the temperature, stirring and homogenizing the mixture uniformly, and then continuously reducing the temperature, wherein the temperature floating range is between 2 and 4 ℃;
step S7, adding the component D when the temperature is reduced to 45 ℃, keeping the temperature, stirring and homogenizing the mixture uniformly when the temperature is in a floating range of 1-2 ℃, and then continuously reducing the temperature;
step S8, when the temperature is reduced to normal temperature, after the sampling analysis result is qualified, discharging to obtain cream for promoting hormone balanced secretion;
and step S9, pushing the obtained cream out of the pot to a standing chamber, aging for 12 hours, and then filling.
In step S4 to step S7, the stirring speed was 40 rpm.
Example 2
A preparation method of a cream for promoting balanced secretion of hormones specifically comprises the following steps:
step S1, sequentially weighing the phase A composition, the phase B composition, the phase C composition, the phase D composition and the traditional Chinese medicine composition according to the weight part ratio;
the phase A composition comprises the following components in parts by weight:
10 parts of glycerol stearate, 6 parts of polydimethylsiloxane, 8 parts of methylparaben, 4 parts of menthol lactate, 4 parts of methyl nicotinate, 6 parts of isostearyl glucoside and 4 parts of propylene glycol; 3 parts of vanillyl butyl ether, 2 parts of blackberry lily root extract and 4 parts of hundred flower fruit extract;
the phase B composition consists of the following components in parts by weight:
25 parts of deionized water, 7 parts of glycerol, 5 parts of betaine, 2 parts of xanthan gum and 1 part of chitosan, wherein the relative molecular weight of the chitosan is 25000;
the phase C composition consists of the following components in parts by weight:
3 parts of saffron extract, 4 parts of maca extract, 3 parts of scutellaria root extract, 3 parts of centella extract, 0.5 part of polygonum cuspidatum root extract and 0.6 part of yeast extract;
the phase D composition consists of the following components in parts by weight:
1 part of oligopeptide, 3 parts of phenoxyethanol and 0.5 part of jojoba oil;
the traditional Chinese medicine composition comprises the following components in parts by weight:
8 parts of angelica sinensis extract, 5 parts of pseudo-ginseng extract, 3 parts of houttuynia cordata extract, 5 parts of dried orange peel extract, 2 parts of motherwort extract, 4 parts of cordyceps militaris powder extract and 6 parts of wolfberry fruit powder extract.
Step S2, heating the A-phase composition to 90 ℃, preserving heat for 25min, and cooling to 80 ℃;
step S3, heating the B-phase composition to 98 ℃, and cooling to 85 ℃ after the colloid is completely dispersed and the temperature is kept for 25 min;
s4, pumping the mixed phase prepared in the S3 into a preheated emulsifying pot, slowly pumping the mixed phase A component mixture prepared in the S2, pre-emulsifying for 22min, homogenizing for 12min, stirring uniformly, vacuumizing and defoaming for 8 hours, wherein the vacuum degree of vacuumizing is-0.09 Mpa;
step S5, adding the Chinese medicinal composition into the mixed solution obtained by emulsification in the step S4, heating to 98 ℃ again, keeping for 12min, and cooling after homogenization treatment;
step S6, adding the component C when the temperature is reduced to 55 ℃, keeping the temperature floating range between 3 ℃, uniformly stirring and homogenizing, and then continuously reducing the temperature;
step S7, when the temperature is reduced to 45 ℃, adding the component D, keeping the temperature, stirring and homogenizing the mixture evenly when the temperature is in a floating range of 1-2 ℃, and then continuously reducing the temperature;
s8, when the temperature is reduced to normal temperature, sampling and analyzing results are qualified, and discharging to obtain the cream for promoting hormone balanced secretion;
and step S9, pushing the obtained cream out of the pot for promoting balanced secretion of hormones into a standing chamber, aging for 12 hours, and then filling.
In step S4 to step S7, the stirring speed was 45 rpm.
Example 3
A preparation method of a cream for promoting balanced secretion of hormones specifically comprises the following steps:
step S1, weighing the phase A composition, the phase B composition, the phase C composition, the phase D composition and the traditional Chinese medicine composition in sequence according to the weight parts;
the phase A composition comprises the following components in parts by weight:
15 parts of glyceryl stearate, 8 parts of polydimethylsiloxane, 10 parts of methylparaben, 6 parts of menthol lactate, 7 parts of methyl nicotinate, 9 parts of isostearyl glucoside and 5 parts of propylene glycol; 4 parts of vanillyl butyl ether, 3 parts of blackberry lily root extract and 6 parts of passion fruit extract;
the phase B composition consists of the following components in parts by weight:
30 parts of deionized water, 9 parts of glycerol, 7 parts of betaine, 5 parts of xanthan gum and 2 parts of chitosan, wherein the relative molecular weight of the chitosan is 30000;
the phase C composition consists of the following components in parts by weight:
5 parts of saffron extract, 6 parts of maca extract, 4 parts of scutellaria root extract, 4 parts of centella extract, 0.8 part of polygonum cuspidatum root extract and 0.9 part of yeast extract;
the phase D composition consists of the following components in parts by weight:
1.5 parts of oligopeptide, 4 parts of phenoxyethanol and 0.8 part of jojoba oil;
the traditional Chinese medicine composition comprises the following components in parts by weight:
10 parts of angelica sinensis extract, 7 parts of pseudo-ginseng extract, 5 parts of houttuynia cordata extract, 6 parts of dried orange peel extract, 3 parts of motherwort extract, 5 parts of cordyceps militaris powder extract and 8 parts of wolfberry fruit powder extract.
Step S2, heating the A-phase composition to 95 ℃, preserving heat for 30min, and cooling to 80 ℃;
step S3, heating the B-phase composition to 100 ℃, and cooling to 85 ℃ after the colloid is completely dispersed and the temperature is kept for 30 min;
step S4, pumping the mixed phase prepared in the step S3 into a preheated emulsifying pot, slowly pumping the mixed phase into the phase A component mixture prepared in the step S2, pre-emulsifying for 5min, homogenizing for 15min, stirring uniformly, vacuumizing and defoaming for 10 hours, wherein the vacuumizing degree is-0.1 Mpa;
step S5, adding the Chinese medicinal composition into the mixed solution obtained by emulsifying in step S4, heating to 100 deg.C again, maintaining for 15min, homogenizing, and cooling
Step S6, adding the component C when the temperature is reduced to 55 ℃, keeping the temperature, stirring and homogenizing the mixture uniformly when the temperature is in a floating range of 2-4 ℃, and then continuously reducing the temperature;
step S7, adding the component D when the temperature is reduced to 45 ℃, keeping the temperature, stirring and homogenizing the mixture uniformly when the temperature is in a floating range of 1-2 ℃, and then continuously reducing the temperature;
step S8, when the temperature is reduced to normal temperature, after the sampling analysis result is qualified, discharging to obtain cream for promoting hormone balanced secretion;
and step S9, pushing the obtained cream out of the pot to a standing chamber, aging for 12 hours, and then filling.
In step S4 to step S7, the stirring speed was 50 rpm.
Comparative example 1
A preparation method of a cream for promoting balanced secretion of hormones specifically comprises the following steps:
step S1, weighing the phase A composition, the phase B composition, the phase C composition and the phase D composition in sequence according to the weight parts;
the phase A composition comprises the following components in parts by weight:
10 parts of glyceryl stearate, 6 parts of polydimethylsiloxane, 8 parts of methylparaben, 4 parts of menthol lactate, 4 parts of methyl nicotinate, 6 parts of isostearyl glucoside and 4 parts of propylene glycol; 3 parts of vanillyl butyl ether, 2 parts of blackberry lily root extract and 4 parts of passion fruit extract;
the phase B composition consists of the following components in parts by weight:
25 parts of deionized water, 7 parts of glycerol, 5 parts of betaine, 2 parts of xanthan gum and 1 part of chitosan, wherein the relative molecular weight of the chitosan is 25000;
the phase C composition consists of the following components in parts by weight:
3 parts of saffron extract, 4 parts of maca extract, 3 parts of scutellaria root extract, 3 parts of centella extract, 0.5 part of polygonum cuspidatum root extract and 0.6 part of yeast extract;
the phase D composition consists of the following components in parts by weight:
1 part of oligopeptide, 3 parts of phenoxyethanol and 0.5 part of jojoba oil;
step S2, heating the A-phase composition to 90 ℃, preserving heat for 25min, and cooling to 80 ℃;
step S3, heating the B-phase composition to 98 ℃, keeping the temperature for 25min after the colloid is completely dispersed, and cooling to 85 ℃;
step S4, pumping the mixed phase prepared in the step S3 into a preheated emulsifying pot, slowly pumping the mixed phase into the phase A component mixture prepared in the step S2, pre-emulsifying for 22min, homogenizing for 12min, stirring uniformly, vacuumizing and defoaming for 8 hours, wherein the vacuumizing degree is-0.09 Mpa;
step S5, when the temperature is reduced to 55 ℃, adding the component C, keeping the temperature floating range between 3 ℃, stirring and homogenizing evenly, and then continuously reducing the temperature;
step S6, adding the component D when the temperature is reduced to 45 ℃, keeping the temperature, stirring and homogenizing the mixture uniformly when the temperature is in a floating range of 1-2 ℃, and then continuously reducing the temperature;
step S7, when the temperature is reduced to normal temperature, after the sampling analysis result is qualified, discharging to obtain the cream with balanced secretion of hormone;
and step S8, pushing the obtained cream out of the pot to a standing chamber, aging for 12 hours, and then filling.
In step S4 to step S7, the stirring speed was 45 rpm.
Comparative example 2
Comparative example 2 a hormone-regulating balance cream was prepared according to the patent publication No. CN 108852966A.
Examples of the experiments
300 women with abnormal hormone secretion are divided into five groups, each group comprises 60 persons, 1-3 groups respectively use the cream for promoting the balanced secretion of the hormones prepared in examples 1-3, and 4-5 groups respectively use the balance cream for regulating the hormones prepared in comparative examples 1-2;
the specific using method is that the balance cream obtained by corresponding preparation is smeared before sleeping every day, and the statistical result is obtained after 30 days of total use, and the obtained result is shown in the following table:
the method has the following advantages: the effects of hectic fever, red face, uneasy sleep, dysphoria, easy generation of qi, hyperhidrosis, urogenital atrophy and urinary incontinence are effectively improved;
and (4) invalidation: tidal fever, red face, restlessness, dysphoria, tendency to generate qi, hyperhidrosis, urogenital atrophy, and urinary incontinence;
adverse reactions: excessive hormone, severe hormonal imbalance;
in conclusion, compared with the balance cream prepared in the comparative examples 1-2, the balance cream prepared in the examples 1-3 of the invention has the advantages that the effects of regulating the hot flushes, the red faces, the uneasy sleep, the anxiety, the qi generation, the hyperhidrosis, the urogenital atrophy and the urinary incontinence of the patients are effectively improved, and the hormone regulation balance degree of the patients is higher.
Although one embodiment of the present invention has been described in detail, the description is only for the purpose of illustrating the preferred embodiments of the present invention and should not be taken as limiting the scope of the invention. All equivalent changes and modifications made within the scope of the present invention shall fall within the scope of the present invention.
Claims (9)
1. A cream for promoting hormone balance secretion is characterized by specifically comprising an A phase composition, a B phase composition, a C phase composition, a D phase composition and a traditional Chinese medicine composition;
the phase A composition consists of the following components in parts by weight:
5-15 parts of glyceryl stearate, 4-8 parts of polydimethylsiloxane, 5-10 parts of methylparaben, 3-6 parts of menthol lactate, 2-7 parts of methyl nicotinate, 4-9 parts of isostearyl glucoside and 3-5 parts of propylene glycol; 1-4 parts of vanillyl butyl ether;
the phase B composition consists of the following components in parts by weight:
20-30 parts of deionized water, 5-9 parts of glycerol and 3-7 parts of betaine;
the phase C composition consists of the following components in parts by weight:
2-5 parts of saffron extract, 3-6 parts of maca extract, 1-4 parts of scutellaria root extract and 2-4 parts of centella extract;
the phase D composition consists of the following components in parts by weight:
0.5-1.5 parts of oligopeptide and 2-4 parts of phenoxyethanol;
the traditional Chinese medicine composition comprises the following components in parts by weight:
6-10 parts of angelica sinensis extract, 3-7 parts of pseudo-ginseng extract, 1-5 parts of houttuynia cordata extract, 2-6 parts of dried orange peel extract, 1-3 parts of motherwort extract, 3-5 parts of cordyceps militaris powder extract and 4-8 parts of wolfberry fruit powder extract.
2. The cream according to claim 1, wherein the phase A composition further comprises the following components in parts by weight: 1-3 parts of blackberry lily root extract and 2-6 parts of hundred flower fruit extract.
3. A cream for promoting balanced secretion of hormones according to claim 2, characterised in that the phase B composition further comprises the following components in parts by weight: 1-5 parts of xanthan gum and 0.5-2 parts of chitosan.
4. The cream for promoting balanced secretion of hormones according to claim 2, wherein the phase C composition further comprises the following components in parts by weight: 0.2-0.8 part of polygonum cuspidatum root extract and 0.3-0.9 part of yeast extract.
5. A cream according to claim 1, wherein the phase D composition further comprises the following components in parts by weight: 0.2-0.8 parts of jojoba oil.
6. A cream for promoting balanced secretion of hormones as claimed in claim 3, wherein the relative molecular weight of chitosan is 20000-30000.
7. A method for preparing a cream for promoting balanced secretion of hormones as claimed in any one of claims 1 to 6, comprising the steps of:
step S1, weighing the phase A composition, the phase B composition, the phase C composition, the phase D composition and the traditional Chinese medicine composition in sequence according to the weight parts;
step S2, heating the composition of the phase A to 85-95 ℃, preserving heat for 20-30min, and cooling to 80 ℃;
step S3, heating the B phase composition to 95-100 ℃, keeping the temperature for 20-30min after the colloid is completely dispersed, and cooling to 85 ℃;
step S4, pumping the mixed phase prepared in the step S3 into a preheated emulsifying pot, slowly pumping the mixed phase into the phase A component mixture prepared in the step S2, pre-emulsifying for 20-25min, homogenizing for 10-15min, stirring uniformly, and vacuumizing for defoaming;
step S5, adding the Chinese medicinal composition into the mixed solution obtained by emulsification in the step S4, heating to 95-100 ℃ again, keeping for 10-15min, and cooling after homogenization treatment;
step S6, adding the component C when the temperature is reduced to 55 ℃, keeping the temperature, stirring and homogenizing the mixture uniformly when the temperature is in a floating range of 2-4 ℃, and then continuously reducing the temperature;
step S7, adding the component D when the temperature is reduced to 45 ℃, keeping the temperature, stirring and homogenizing the mixture uniformly when the temperature is in a floating range of 1-2 ℃, and then continuously reducing the temperature;
s8, when the temperature is reduced to normal temperature, sampling and analyzing results are qualified, and discharging to obtain the cream for promoting hormone balanced secretion;
and step S9, pushing the obtained cream out of the pot for promoting balanced secretion of hormones into a standing chamber, aging for 12 hours, and then filling.
8. A method of preparing a cream for promoting balanced secretion of hormones as claimed in claim 7, wherein in said step S4, vacuum degree of vacuum pumping is between-0.08 MPa and-0.1 MPa, and defoaming is carried out for 5 to 10 hours.
9. A method of preparing a cream for promoting balanced secretion of hormones as claimed in claim 7, wherein the stirring speed in steps S4-S7 is 40-50 rpm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210442891.0A CN114767582A (en) | 2022-04-25 | 2022-04-25 | Cream for promoting balanced secretion of hormones and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210442891.0A CN114767582A (en) | 2022-04-25 | 2022-04-25 | Cream for promoting balanced secretion of hormones and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114767582A true CN114767582A (en) | 2022-07-22 |
Family
ID=82432239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210442891.0A Pending CN114767582A (en) | 2022-04-25 | 2022-04-25 | Cream for promoting balanced secretion of hormones and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114767582A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106334090A (en) * | 2016-11-10 | 2017-01-18 | 西藏城宇生物科技有限公司 | Traditional Chinese medicine composition for anti-fatigue and nourishing yin and tonifying yang and preparing method thereof |
| CN108852966A (en) * | 2018-08-03 | 2018-11-23 | 广州维顿生物科技有限公司 | It is a kind of to adjust hormonal equilibrium cream and preparation method thereof |
| CN113181100A (en) * | 2021-05-14 | 2021-07-30 | 博雅凰巢(北京)生物科技有限公司 | Herbal essence skin-care balance cream and preparation method thereof |
-
2022
- 2022-04-25 CN CN202210442891.0A patent/CN114767582A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106334090A (en) * | 2016-11-10 | 2017-01-18 | 西藏城宇生物科技有限公司 | Traditional Chinese medicine composition for anti-fatigue and nourishing yin and tonifying yang and preparing method thereof |
| CN108852966A (en) * | 2018-08-03 | 2018-11-23 | 广州维顿生物科技有限公司 | It is a kind of to adjust hormonal equilibrium cream and preparation method thereof |
| CN113181100A (en) * | 2021-05-14 | 2021-07-30 | 博雅凰巢(北京)生物科技有限公司 | Herbal essence skin-care balance cream and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103585097B (en) | Epidermal growth factor-loaded bletilla rhizome polysaccharide compound, and preparation method and application thereof | |
| CN110339131B (en) | Repairing emulsion and preparation method thereof | |
| CN110787100A (en) | Anti-allergy skin-soothing essence and preparation method thereof | |
| CN112022776B (en) | Whitening essence and preparation method thereof | |
| CN110496072A (en) | A kind of vibration massage function eye cream of the filtrate containing glossy ganoderma fermentation and preparation method thereof | |
| CN113648271A (en) | Hair loss prevention and hair growth composition and preparation method thereof | |
| CN109939064A (en) | The Essence of the metabolite containing probiotics fermention and its application in cosmetics | |
| CN108670933B (en) | Skin care composition with moisturizing, whitening and anti-aging functions and application thereof | |
| CN109394850B (en) | Traditional Chinese medicine composition with skin aging delaying effect, aqueous extract and fermentation product of traditional Chinese medicine composition and application of traditional Chinese medicine composition | |
| CN112516054B (en) | Tea polyphenol protein cream for repairing, moisturizing and strengthening skin and production process thereof | |
| CN113208971A (en) | Whitening, anti-wrinkle, firming and freckle-removing cream | |
| CN113712883A (en) | Repairing cream containing dendrobium officinale extract and preparation method of repairing cream | |
| CN114767582A (en) | Cream for promoting balanced secretion of hormones and preparation method thereof | |
| CN107019070A (en) | A kind of tea for reducing dermal melanin and preparation method thereof | |
| CN102058513A (en) | Chinese herbal medicine crude solution and cosmetic containing same | |
| CN115364039B (en) | Acne skin repair composition and application thereof | |
| CN111297772A (en) | Ganoderma lucidum Chinese herbal medicine anti-hair loss and hair growth liquid and preparation method thereof | |
| CN115414289A (en) | Cordyceps flower cosmetics and preparation method thereof | |
| CN113440470A (en) | Composition for effectively relieving discomfort of skin staying up all night and preparation method and application thereof | |
| CN114748386A (en) | Preparation method and application of seven-white Chinese herbal medicine fermented raw juice with whitening effect | |
| CN113181100A (en) | Herbal essence skin-care balance cream and preparation method thereof | |
| CN113491664A (en) | Composition for quickly relieving pruritus as well as preparation method and application thereof | |
| CN112137947A (en) | Preparation method of special-effect high-moisture-retention emulsion | |
| CN106551893A (en) | One kind treats hormone dermatitis cosmetics and preparation method thereof | |
| CN111494301A (en) | Cell anti-aging repair cream and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220722 |